Pediatric rheumatology

Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus

LupusPublished Cross-sectional study

Authors' conclusion

Our study showed that AC-4/5 and AC-1 patterns of ANA are frequently detected in many clinical and serological features of childhood-onset SLE patients.

Study context

Population
Patients with childhood-onset systemic lupus erythematosus (SLE)F/M = 3/1
Participants
223 patients
Outcome
Frequency of ANA staining patterns in disease-related features
Methodological detailsMedian age at diagnosis 14.3 (11.9-16.1) years
  • Median age at diagnosis 14.3 (11.9-16.1) years

Main finding

As reported in the abstract

ANA staining patterns

AC-4/5 (fine or large speckled): most common nuclear antinuclear antibodies (ANA) pattern

75.8%

AC-19 (dense fine speckled): most frequent cytoplasmic ANA pattern

13.1%

Observational data: associations, not effects.

Further findings

ANA patterns by clinical features

AC-4/5 notably seen in fever, acute and chronic cutaneous lupus, arthritis, serositis, hematologic, renal, neuropsychiatric, gastrointestinal and cardiopulmonary involvement
all p < .001
AC-1 (homogeneous) significantly detected in oral/nasal ulcers and non-scarring alopecia
both p < .001

ANA patterns by laboratory features

AC-4/5 predominant in autoimmune hemolytic anemia, leukopenia, thrombocytopenia, elevated ESR and CRP, hypocomplementemia, direct Coombs, anti-Sm, anti-SSA and SS-B, anti-RNP, anti-histone, anti-ribosomal P, LA, aCL IgM/IgG and anti-β2-glycoprotein IgM/IgG positivities
all p < .001
AC-1 detected in anti-dsDNA and anti-histone positivity
both p < .001

Original publication

Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus. Lupus. Published 27 November 2024. doi:10.1177/09612033241305198

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.